Management of Hypomagnesaemia

Use of magnesium for other indications e.g. eclampsia is outside the scope of this guideline. The reference range for serum magnesium is 0.7-1mmol/L. Serum concentrations should be used in conjunction with presenting signs and symptoms to diagnose hypomagnesaemia (see notes below).

Adults with normal renal function

Magnesium levels should be monitored and the dose adjusted as necessary. See flowchart below.

Adults with renal impairment

In patients with renal impairment, reduced urinary magnesium excretion puts the patient at risk of hypermagnesaemia. See flowchart below for dosing guidance.

N.B. Doses shown in the flowchart are suggested starting doses. Further advice is available from the Biochemistry Department.

Additional information

    • Magnesium is mainly an intracellular ion, so serum concentrations are not an exact measurement of total body stores.
    • Magnesium depletion is often associated with other electrolyte abnormalities - reduced K+, Ca2+, PO43- or Na+ levels may co-exist with a low Mg2+.
    • Possible symptoms include agitation, confusion, convulsions, weakness, tremors, ECG changes, nausea and vomiting.
    • Establish and correct cause of hypomagnesaemia if possible. See Table 1 for potential causes.

N.B. Severe hypoalbuminaemia may result in low serum magnesium. Seek senior advice if unsure how to proceed.

Table 1 - Potential causes of low magnesium

Cause Examples
Redistribution    Refeeding syndrome
Gastrointestinal
  • Diarrhoea and vomiting
  • Malabsorption
  • Medication (e.g. PPI, laxatives)
  • Gastrointestinal fistulae
  • Short bowel syndrome
  • Malnutrition/dietary deficiency (uncommon)
Renal losses
  • Medications (e.g. thiazide or loop diuretics, amphotericin, aminoglycosides, cisplatin, ciclosporin, tacrolimus)
  • Diabetes mellitus/glycosuria (osmotic diuresis), diabetic ketoacidosis
  • Alcoholism (particularly if associated with poor nutrition)
  • Hypercalcaemic states
  • Hyperaldosteronism, hyperthyroidism, diabetes insipidus
  • Renal tubular disorders
  • Inherited disorders (e.g. Bartter or Gitelman syndrome)
  • Post-renal transplant
  • Dialysis

Guideline reviewed: August 2026

Page last updated: November 2026